Company Name: |
TargetMol Chemicals Inc.
|
Tel: |
4008200310 |
Email: |
marketing@tsbiochem.com |
Products Intro: |
Product Name:CDK7/12-IN-1 CAS:2654075-94-0 Purity:98% Package:10 mg;5 mg
|
Company Name: |
Shanghai?Medlife?Pharm-Tech?Co.,?Ltd
|
Tel: |
021-59167510 18117107507 |
Email: |
vip@med-life.cn |
Products Intro: |
Product Name:CDK7/12-IN-1 CAS:2654075-94-0 Purity:>=99% Package:1mg;5mg;50mg;10mg
|
|
| 3-Piperidinol, 4-[[[7-[[(2,7-dimethylimidazo[1,2-a]pyridin-3-yl)methyl]amino]-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]-, (3R,4R)- Basic information |
Product Name: | 3-Piperidinol, 4-[[[7-[[(2,7-dimethylimidazo[1,2-a]pyridin-3-yl)methyl]amino]-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]-, (3R,4R)- | Synonyms: | 3-Piperidinol, 4-[[[7-[[(2,7-dimethylimidazo[1,2-a]pyridin-3-yl)methyl]amino]-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]-, (3R,4R)-;CDK7/12-IN-1 | CAS: | 2654075-94-0 | MF: | C25H34N8O | MW: | 462.59 | EINECS: | | Product Categories: | | Mol File: | 2654075-94-0.mol | ![3-Piperidinol, 4-[[[7-[[(2,7-dimethylimidazo[1,2-a]pyridin-3-yl)methyl]amino]-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]-, (3R,4R)- Structure](CAS/20210305/GIF/2654075-94-0.gif) |
| 3-Piperidinol, 4-[[[7-[[(2,7-dimethylimidazo[1,2-a]pyridin-3-yl)methyl]amino]-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]-, (3R,4R)- Chemical Properties |
density | 1.37±0.1 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO : 100 mg/mL (216.17 mM; Need ultrasonic) | form | Solid | pka | 14.69±0.40(Predicted) | color | White to light brown |
| 3-Piperidinol, 4-[[[7-[[(2,7-dimethylimidazo[1,2-a]pyridin-3-yl)methyl]amino]-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]-, (3R,4R)- Usage And Synthesis |
Biological Activity | CDK7/12-IN-1 is a selective CDK7/12 inhibitor with IC50s of 3 and 277 nM for CDK7 and CDK 12, respectively. CDK7 and CDK12 inhibition is an effective strategy to inhibit tumour growth[1]. | References | [1]. Edward AINSCOW, et al. 4-[[(7-aminopyrazolo[1,5-a]pyrimidin-5-yl)amino]methyl]piperidin-3-ol compounds and their therapeutic use. WO2021122745A1. |
| 3-Piperidinol, 4-[[[7-[[(2,7-dimethylimidazo[1,2-a]pyridin-3-yl)methyl]amino]-3-(1-methylethyl)pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]-, (3R,4R)- Preparation Products And Raw materials |
|